Article Information
History
- September 16, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Sumito Inoue1,*,
- Akira Igarashi1,
- Keita Morikane2,
- Osamu Hachiya3,
- Masafumi Watanabe1,
- Seiji Kakehata4,
- Shinya Sato5 and
- Yoshiyuki Ueno6
- 1Department of Cardiology, Pulmonology, and Nephrology, Yamagata University Faculty of Medicine, Japan
- 2Division of Clinical Laboratory and Infection Control, Yamagata University Hospital, Japan
- 3Division of Infection Control, Yamagata University Hospital, Japan
- 4Department of Otolaryngology Head and Neck Surgery, Yamagata University Faculty of Medicine, Japan
- 5Yamagata University Hospital, Yamagata University Faculty of Medicine, Japan
- 6Department of Gastroenterology, Yamagata University Faculty of Medicine, Japan
- ↵*Corresponding author: Sumito Inoue, Department of Cardiology, Pulmonology, and Nephrology, Yamagata University, Faculty of Medicine, Yamagata, Japan, 2-2-2, Iida-Nishi, Yamagata, Japan, 990-9585, Email: sinoue{at}med.id.yamagata-u.ac.jp
Posted September 16, 2021.
Adverse reactions to BNT162b2 mRNA COVID-19 vaccine in medical staffs with a history of allergy
